GeneDx Holdings (WGS) Capital Expenditures Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.89% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 81.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.59% |
| Mar 31, 2026 | 81.85% |
| Dec 31, 2025 | -66.49% |
| Sep 30, 2025 | 92.51% |
| Jun 30, 2025 | 20.03% |
| Mar 31, 2025 | 64.45% |
| Dec 31, 2024 | 87.66% |
| Sep 30, 2024 | -6.64% |
| Jun 30, 2024 | -75.78% |
| Mar 31, 2024 | -40.23% |
| Dec 31, 2023 | -100.56% |